These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2201044)

  • 21. [Trials of immunotherapy in tumors of the urinary tract].
    Corrado F; Pizza G
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():659-66. PubMed ID: 6336141
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy for metastatic renal cell carcinoma.
    McDermott DF; Rini BI
    BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunology in clinical practice. XVII. Immunotherapy of metastatic renal cell carcinoma. Work Group Immunotherapy, Dutch Oncology].
    van Herpen CM; de Mulder PH
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2613-8. PubMed ID: 10028361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma.
    Little B; Young M; Ho KJ
    Int J Clin Pract; 2002; 56(1):36-9. PubMed ID: 11831831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
    Ramsey S; Aitchison M
    J Urol; 2005 Dec; 174(6):2422-3. PubMed ID: 16280863
    [No Abstract]   [Full Text] [Related]  

  • 27. New drug therapies for advanced renal cell carcinoma.
    Gore ME; Harrison ML; Montes A
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):57-71. PubMed ID: 17187520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.
    Shaheen PE; Bukowski RM
    Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic therapy of metastatic renal cell carcinoma.
    Vugrin D
    Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy for renal cell carcinoma.
    Amato RJ
    Semin Oncol; 2000 Apr; 27(2):177-86. PubMed ID: 10768596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in renal cell cancer immunotherapy.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic therapy of renal cell carcinoma.
    Grünwald V; Ravaud A
    World J Urol; 2014 Feb; 32(1):1. PubMed ID: 24408477
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of Advanced Renal-Cell Carcinoma.
    Motzer RJ; Escudier B; Choueiri TK
    N Engl J Med; 2016 Mar; 374(9):889-90. PubMed ID: 26962911
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Advanced Renal-Cell Carcinoma.
    Huillard O; Alexandre J; Goldwasser F
    N Engl J Med; 2016 Mar; 374(9):888. PubMed ID: 26962912
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Advanced Renal-Cell Carcinoma.
    Santini D; Tonini G
    N Engl J Med; 2016 Mar; 374(9):888-9. PubMed ID: 26962913
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.
    Bracarda S; Altavilla A; Hamzaj A; Sisani M; Marrocolo F; Del Buono S; Danielli R
    Semin Oncol; 2015 Jun; 42(3):495-505. PubMed ID: 25965369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney cancer therapy: new perspectives and avenues.
    Alexandrescu DT; Dasanu CA
    Expert Opin Pharmacother; 2006 Dec; 7(18):2481-93. PubMed ID: 17150003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of established human renal cell carcinoma heterotransplanted in nude mice. 2. Experimental chemosensitivity of anticancer agents].
    Onishi T; Masuda F
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1911-20. PubMed ID: 6535021
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of cytotoxic chemotherapy, 1983-1988, and the emerging role of monoclonal antibodies for renal cancer.
    Yagoda A; Bander NH
    Urol Int; 1989; 44(6):338-45. PubMed ID: 2696193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durable Responses With PD-1 Inhibition in Lung and Kidney Cancer and the Ongoing Search for Predictive Biomarkers.
    Awad MM; Hammerman PS
    J Clin Oncol; 2015 Jun; 33(18):1993-4. PubMed ID: 25918290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.